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Resumo 
Os neurónios são a unidade funcional sinalizadora do sistema nervosa central (SNC). 
Estes comunicam entre si através da propagação de sinais eléctricos conhecidos como 
potenciais de acção. Os neurónios apresentam um potencial de membrana de repouso 
negativo, mantido principalmente através de canais de potássio não dependentes de voltagem. 
A formação de um potencial de acção ocorre através de um fluxo de corrente despolarizante 
suficiente para desencadear um fenómeno de “tudo ou nada”. Este resulta da abertura rápida 
de canais de sódio (Na+) dependentes de voltagem, que despolarizam a membrana, e canais de 
potássio (K+), também dependentes de voltagem, que repõem o potencial de membrana da 
célula. 
A sinapse é o local de contacto funcional entre um neurónio e a célula alvo (que pode 
ou não ser uma célula nervosa). A transmissão de informação entre um neurónio pré-sináptico 
e a célula pós-sináptica designa-se por transmissão sináptica. Existem duas formas de 
transmissão numa sinapse: eléctrica e química. Nas sinapses eléctricas existem junções 
comunicantes que permitem a transmissão de informação entre as células; na sinapse química 
a comunicação é possível através da libertação de agentes químicos, os neurotransmissores, 
que atravessam um espaço extracelular designado por fenda sináptica. O neurotransmissor é 
libertado pré-sinapticamente através de vesículas e activa receptores específicos pós-
sinápticos. 
Existem duas classes de neuroreceptores: receptores ionotrópicos e receptores 
metabotrópicos. Os primeiros são canais iónicos que permitem a passagem de iões e medeiam 
a transmissão sináptica rápida; os receptores metabotrópicos estão associados a proteínas G e 
medeiam a transmissão sináptica lenta, que persiste durante segundos ou minutos. 
No SNC de um mamífero adulto, o glutamato e o ácido γ-aminobutírico (GABA) são 
os dois principais neurotransmissores excitatório e inibitório, respectivamente. A integração 
de diferentes estímulos, inibitórios e excitatórios, numa célula nervosa, é de extrema 
importância para o correcto funcionamento do SNC.  
As acções do GABA são mediadas através de duas classes distintas de receptores: os 
receptores GABAA (canais iónicos, selectivamente permeáveis ao cloro (Cl-) e bicarbonato 
(HCO3-)) e os receptores GABAB (acoplados a proteínas G que diminuem os níveis de cAMP 
e activam os canais de K+). Os receptores GABAA são pentameros heteroméricos constituídos 
por cinco de dezanove subunidades possíveis. Quando o neurotransmissor GABA é libertado 
para a fenda sináptica, este pode ligar-se extracelularmente ao receptor GABAA pós-sináptico 
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induzindo alterações conformacionais que resultam num aumento da permeabilidade do canal 
a aniões Cl- e HCO3- ; quando o GABA é removido da fenda sináptica, o canal fecha ficando 
assim disponível para a ligação de outra molécula de GABA. Os receptores GABAA podem 
também ser activados por análogos estruturais do GABA, como o muscimol, um produto 
natural retirado dos cogumelos alucinogénicos Amanita muscaria. Os receptores 
metabotrópicos GABAB estão localizados pré-sinapticamente, reduzindo a libertação de 
neurotransmissores, e pós-sinapticamente, activando canais de K+ e hiperpolarizando a 
membrana. 
Para além dos neurotransmissores, existem outras moléculas que não medeiam 
directamente a transmissão sináptica, mas que têm a capacidade de alterar e modular este 
fenómeno, designadas por neuromoduladores. Um exemplo muito importante deste tipo de 
moléculas no SNC é a adenosina. 
A adenosina é um nucleósido de purina envolvida na modulação de respostas 
fisiológicas numa grande variedade de tecidos e circunstâncias. No SNC, a adenosina actua 
como molécula sinalizadora extracelular, envolvida tanto em processos normais como 
patofisiológicos, de que são exemplo a regulação do sono, neuroprotecção e controlo de  
epilepsia. O efeito modulador da adenosina é mediado por quatro tipos de receptores 
acoplados a proteínas G, designados por receptores A1, A2A, A2B e A3. Os dois primeiros (A1 e 
A2A) são receptores de alta afinidade, e com maior importância fisiológica; o receptor A2B 
aparece mais associado a condições patofisiológicas; o receptor A3 é também um receptor de 
alta afinidade, mas de baixa expressão na maioria dos tecidos. Os receptores A1 são os mais 
abundantes dos receptores de adenosina, sendo expressos numa grande variedade de tecidos e 
órgãos. Ao nível do SNC o receptor A1 é principalmente expresso no córtex, cerebelo, 
hipocampo e espinal medula. A sinalização é feita via proteínas Gi e Go inibindo a adenilato 
ciclase, activando vários tipos de canais de K+ e inactivando canais de cálcio (Ca2+) bem 
como a via de sinalização fosfolipase C/proteína cinase C. Os receptores A2A surgem 
maioritariamente ao nível do bolbo olfativo e neurónios GABAérgicos do estriado. No 
entanto, foi também identificada a presença de mRNA dos receptores A2A no córtex e 
hipocampo. Estes receptores estão acoplados preferencialmente a proteínas estimuladoras 
(Gs), induzindo a actividade da adenilado ciclase e, consequentemente, aumentando as 
concentrações de AMP cíclico (cAMP) na célula. 
O hipocampo é uma estrutura cerebral envolvida fundamentalmente na formação e 
associação de memórias e orientação espacial. Apresenta um circuito neuronal unidireccional 
constituído por três áreas principais: Giros Dentado (DG), com células granulares a 
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constituírem a principal camada (stratum granulosum); área CA3, enervada pelos axónios das 
células granulares do DG e constituída por uma camada de células piramidais principal 
(stratum piramidales); área CA1, também constituída por uma camada de células piramidais e 
enervada pelos axónios projectados da região CA3. Associado às células principais 
excitatórias está um sistema complexo de interneurónios inibitórios GABAérgicos. Quando se 
preparam fatias transversais de hipocampo, a organização laminar neuronal é visualmente 
reconhecida e o circuito hipocampal é preservado. A actividade eléctrica das células do 
hipocampo pode ser monitorizada por registos electrofisiológicos de uma única célula, através 
da técnica de patch-clamp. 
Os registos de patch-clamp podem ser feitos em vários tipos de configuração, sendo 
que o mais largamente utilizado é a configuração whole-cell patch-clamp. Esta permite 
registos que envolvem toda a célula, e não apenas um retalho da membrana, bem como a 
aplicação de fármacos ou moduladores na pipeta intracelular, a fim de estudar cascatas de 
sinalização associadas a diferentes fenómenos. 
A adenosina actua no hipocampo como modulador da excitabilidade neuronal, quer 
por acção directa nos circuitos excitatórios, quer por modificações da inibição GABAérgica. 
Estudos anteriores focam-se maioritariamente no papel modulador da adenosina na 
comunicação glutamatérgica e na função GABAérgica pré-sináptica. No entanto, pouco se 
sabe sobre um possível papel da adenosina na modulação GABAérgica pós-sináptica.  
Assim, neste trabalho pretendeu-se investigar o papel da adenosina (via receptores A2A 
e A1) nas correntes inibitórias pós-sinápticas mediadas pelos receptores GABAA nas células 
piramidais da região CA1 do hipocampo de rato. Foram feitos registos de whole-cell patch-
clamp. Os neurónios piramidais foram identificados pela sua localização específica na região 
CA1 e pelo padrão de disparo característico de células piramidais. As correntes GABAérgicas 
mediadas pelos receptores GABAA foram evocadas pela aplicação de puffs de 30µM de 
muscimol (agonista selectivo dos receptores GABAA) a cada 2 minutos, durante 10ms a 6psi. 
Agonistas e antagonistas dos receptores de adenosina foram aplicados à solução de perfusão 
de forma a garantir penetração dos fármacos no tecido e assim haver equilíbrio entre os 
fármacos e os seus receptores; foram avaliadas alterações na amplitude das correntes 
evocadas pelo muscimol. 
Começou-se por avaliar o efeito dos receptores de adenosina A2A nas correntes 
GABAérgicas pós-sinápticas evocadas por muscimol. Verificou-se que a aplicação de 30nM 
de CGS 21680 (agonista selectivo dos receptores A2A de adenosina) não alterou a amplitude 
das correntes pós-sinápticas mediadas pelos receptores GABAA nas células piramidais de 
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CA1. Esta inexistência de efeito poderá dever-se a uma ausência de co-localização dos 
receptores de adenosina A2A com os receptores GABAA nestes neurónios piramidais. Outra 
justificação implicaria que a via de transdução de sinal associada aos receptores de adenosina 
não levasse a alterações dos receptores GABAA. Esta última hipótese parece ser menos 
provável na medida em que os receptores GABAA parecem ser fosforilados pela proteína 
cinase A (PKA), normalmente associada à via de transdução de sinal dos receptores A2A, 
levando a alterações funcionais na transmissão GABAérgica. 
Os receptores de adenosina A1 são muito mais abundantes no hipocampo que os 
receptores A2A e estão também associados à sinalização via PKA, embora, neste caso, 
inibindo a sua actividade. Foi também observado que os receptores A1 estão altamente 
expressos na componente neuronal pós-sináptica, sugerindo um envolvimento destes 
receptores na integração dendrítica. Fomos então investigar se os receptores A1 de adenosina, 
ao contrário dos receptores A2A, conseguem modular as correntes pós-sinápticas mediadas 
pelos receptores GABAA. Para testar esta hipótese aplicou-se à solução de perfusão um 
agonista selectivo dos receptores A1, CPA (10nM), após um período de estabilização da 
amplitude das correntes evocadas por muscimol. Observou-se que o CPA induziu uma 
diminuição rápida da amplitude das correntes mediadas pelos receptores GABAA para 54% ± 
3,9% (n = 12, p<0.0001) do seu valor inicial. Esta inibição verificou-se em 12 das 17 células 
testadas. Em registo electrofisiológicos de célula única, é habitual que algumas células não 
respondam a deteminado tratamento farmacológico. Este fenómeno deve-se à variabilidade 
existente entre neurónios de uma população celular. O efeito do CPA não foi revertido após 
30 minutos de lavagem do fármaco do banho; contudo este efeito foi revertido com a 
aplicação de DPCPX (50nM), um antagonista selectivo dos receptores A1 (recuperação para 
84% ± 6,5% do nível de pré-controlo, n=3, p<0,001). 
Para confirmar que a inibição das correntes mediadas pelos receptores GABAA 
envolve especificamente os receptores A1, testou-se o efeito do agonista CPA (30nM) na 
presença de DPCPX (100nM). Como esperado, o DPCPX adicionado antes do CPA preveniu 
o efeito do CPA nas correntes inibitórias pós-sinápticas mediadas pelos receptores GABAA 
(100% ± 0,6% da linha basal, n=5, p=0,503, comparando com o nível de pré-controlo). 
Ocorreu também um pequeno aumento nas correntes GABAérgicas após a aplicação do 
DPCPX para 113% ± 1,0% (n=5, p<0,001, comparando com o nível de pré-controlo), 
sugerindo um efeito inibitório tónico da adenosina extracelular endógena nas correntes 
mediadas pelos receptores GABAA. Após aplicação de CPA e ainda na presença de DPCPX 
houve uma pequena diminuição nas correntes pós-sinapticas evocadas por muscimol para o 
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nível de pré-controlo muito provavelmente devido à competição dos dois fármacos pelo 
mesmo local de ligação ao receptor A1. 
A componente GABAérgica foi isolada de qualquer interferência da transmissão 
glutamatérgica rápida (via receptores AMPA/Cainato) e lenta (via receptores NMDA), bem 
como do disparo de potencias de acção. Nestas condições, o efeito inibitório do CPA 
continuou a ser observado, tendo este agonista diminuído as correntes evocadas por muscimol 
para 60% ± 8,3% (n=4, p<0,05, comparando com o nível de pré-controlo) do seu valor inicial, 
indicando que o efeito dos receptores A1 nas correntes GABAérgicas é independente da 
componente excitatória que chega às células piramidais de CA1. 
Estes dados mostram claramente um efeito pós-sináptico dos receptores A1 nas 
correntes mediadas pelos receptores GABAA, nas células piramidais da região CA1 do 
hipocampo. Um estudo anterior mostrou que os receptores A1 não modulam as correntes 
GABAérgicas evocadas electricamente por estimulação aferente; outros estudos sugerem que 
os receptores A1 apenas modulam pré-sinapticamente a libertação de GABA, não 
influenciando as correntes GABAérgicas pós-sinápticas. Estas discrepâncias aparentes com os 
nossos resultados podem ser facilmente explicadas pelas diferenças no protocolo utilizado, 
uma vez que os estudos anteriores restringiram-se a avaliar o efeito modulador da adenosina 
apenas na componente sináptica, enquanto no presente trabalho estimulou-se directamente o 
soma da célula, activando também os receptores GABAA extra-sinápticos. Desta forma, é 
provável que a acção dos receptores A1 nas correntes GABAérgicas seja maioritariamente 
exercita nesta componente extra-sináptica. Os receptores GABAA extra-sinápticos estão 
principalmente envolvidos na inibição tónica – uma forma de inibição persistente devido a 
activação contínua dos receptores GABAA. Este tipo de inibição tónica tem um papel 
importante na integração do sinal sináptico, bem como em condições patológicas, como certos 
tipos de epilepsia, em que a concentração ambiente de GABA está diminuída. A modulação 
das correntes inibitórias tónicas pode representar uma estratégia promissora para o 
desenvolvimento de novos fármacos anticonvulsivos.  
No seu conjunto, estes resultados demonstram a capacidade dos receptores A1 de 
adenosina de inibirem as correntes pós-sinápticas mediadas pelos receptores GABAA em 
células piramidais da região CA1. Este fenómeno é completamente independente da 
transmissão sináptica excitatória e é exercido tonicamente por níveis extracelulares endógenos 
de adenosina no hipocampo. Os receptores de adenosina A2A, ao contrário dos receptores A1, 
não parecem modular as correntes GABAérgicas nos mesmos neurónios. 
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Estudos adicionais sobre a modulação da adenosina nos sinais inibitórios que chegam 
aos interneurónios GABAérgicos serão fundamentais para compreender o papel da adenosina 
no controlo da inibição no hipocampo.  
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Abstract 
Much of what is known about the modulatory role of adenosine in the hippocampus is 
on glutamatergic communication and presynaptic GABAergic function. However, any 
possible role of adenosine on responses of the postsynaptic cell to GABA had not been 
evaluated. The effect of A1 and A2A receptor activation on inhibitory postsynaptic currents 
(PSCs) mediated by GABAA receptors was now examined in CA1 pyramidal neurons of 
young (3-5 weeks) rat hippocampal slices by using the whole-cell patch-clamp technique 
(Vh=-80mV). GABAA-mediated currents were evoked through pressure application of 
muscimol (30µM), a GABAA receptor agonist, directly to the cell soma. Bath application of a 
selective A2A receptor agonist, CGS 21680 (30nM), induced no statistically significant 
differences on muscimol-evoked currents (101%±2,1% of baseline, n=6, p=0,715). The 
superfusion of the adenosine A1 receptor agonist, CPA (10-30nM), significantly decreased the 
peak amplitude of GABAergic responses with a maximum effect (to 54%±3,9% of pre-
control value, n=12, p<0.0001) observed within 45 min after its application. This effect of 
CPA was not reversible within 40min after washing it out from the bath. However, the 
application of DPCPX (50nM), an adenosine A1 receptor antagonist, induced the recovery of 
the PSCs towards 84%±6,5% of pre-control value (n=3, p<0,001 compared with CPA 
(10nM)). Pre-incubation with DPCPX (100nM) also blocked the effect of CPA (30nM) on 
GABAA receptor currents (100%±0,6% of the baseline, n=5, p=0,503) and unmasked the 
inhibition of PSCs by endogenous extracellular adenosine (113%±1,0% to 100%±0,6%, n=5, 
p<0,001). This phenomenon is independent of excitatory inputs arriving to pyramidal CA1 
neurons since the CPA effect was maintained (to 60%±8,3%, n=4, p<0,05) in the presence of 
blockers of excitatory transmission (CNQX (10µM); DL-AP5 (50µM); TTX (500nM)). 
Together, these results suggest that postsynaptic GABAA-mediated currents are modulated by 
adenosine A1, but not A2A receptor, in rat hippocampal CA1 pyramidal cells. 
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1. Aims 
The present work was designed to evaluate the adenosine A1 and A2A receptor-mediated 
neuromodulation of postsynaptic inhibitory GABAA receptor currents in hippocampal CA1 
pyramidal cells. We also aimed to investigate the cellular distribution of A1, A2A and GABAA 
receptors in these hippocampal neurons, looking for some possible co-localization between them. 
Modulatory effects of adenosine on inhibitory inputs to pyramidal cells were evaluated by 
using the patch-clamp technique and receptors distribution in hippocampal slices with 
immunohistochemistry techniques. 
 
2. Introduction 
2.1 Synaptic transmission 
Santiago Ramón y Cajal noticed over a century ago that neurons serve as the functional 
signalling units of the nervous system (Ramon y Cajal, 1911). Neurons connect to one another in 
precise ways and the information is transmitted by the generation and propagation of an electrical 
signal known as the action potential (Adrian, 1957). Generally, neurons generate a negative 
potential, called the resting membrane potential, which is transiently abolished by a flow of 
depolarizing current sufficient to trigger an all-or-none action potential (Hodgkin, 1937). The 
resting membrane potential is explained in terms of voltage-insensitive channels permeable 
primarily to K+, and the generation and propagation of the action potential in terms of two 
voltage-gated conductances: one selective to Na+ and the other selective to K+ (Hodgkin et al., 
1952). 
Given the number of neurons in the brain (more than 100 thousand million neurons in 
human brain), sophisticated and highly efficient mechanisms are needed to enable 
communication among them. Such communication is made possible by synapses, the 
fundamental contacts between neurons (Sherrington, 1906 in Breathnach, 2005). Two different 
types of synapses – electrical and chemical – can be distinguished (Bennett, 1977 in Bennett, 
2000). At electrical synapses, transmission depends on current through gap junctions that bridge 
the cytoplasm of pre- and postsynaptic cells; at chemical synapses, pre- and postsynaptic cells are 
separated by an extracellular space, the synaptic cleft, and the communication is made possible 
by the secretion of chemical agents called neurotransmitters. The transmitter is released by the 
1 
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presynaptic neurons and activates specific receptor molecules in postsynaptic cells – the 
neurotransmitter receptors. 
There are two major classes of transmitter receptors: ionotropic receptors, in which the 
receptor molecule is also an ion channel producing rapid synaptic potentials lasting only a few 
milliseconds; and metabotropic receptors, in which the receptor and the ion channel are separate 
molecules indirectly linked through signal transduction mechanisms, producing a slower synaptic 
response which persists for seconds or minutes (for review see Devi, 2005). 
Depending on which neurotransmitter is mainly produced by the presynaptic cell and the types of 
receptors that are expressed in the postsynaptic cell, we can characterize the synapses as 
excitatory or inhibitory. In the adult mammalian central nervous system (CNS), glutamate and 
GABA (gamma-aminobutiric acid) are the main excitatory and inhibitory transmitters, 
respectively. The integration of inhibitory and excitatory inputs arriving to the same cell soma is 
of maximum importance for the correct functioning of the CNS (Eccles, 1953 in Albright et al., 
2000). 
 
2.1.1 Gamma-Aminobutiric Acid (GABA) 
GABA was first identified and isolated in the mammalian brain by two independent 
groups over half a century ago (Awapara, 1950; Roberts, 1950). The first evidence for an 
inhibitory role of GABA arose during 1950´s and 1960´s with the findings that GABA strongly 
suppressed electrical activity in mammalian nervous system and large amounts of GABA were 
found only in the inhibitory axons (Florey, 1955; Kravitz, 1963). 
GABAergic inhibition results from activation of two different types of receptors: 
ionotropic GABAA receptors (GABAARs) that mediate fast inhibitory responses; and 
metabotropic G-protein coupled GABAB receptors that mediate slow inhibitory responses 
(Bormann, 1988 in Owens, 2002). Another ionotropic GABA receptor termed GABAC receptor 
has also been identified (see Bormann, 1995) with prominent distributions on retinal neurons but 
functionally and pharmacologically less well-characterized. 
GABAARs are members of the nicotinicoid superfamily of ligand-gated ion channels that 
includes nicotinic acetylcholine receptors, glycine receptors and a subtype of 5-
hydroxytryptamine receptors (5-HTR). They are heteromeric pentamers composed of five 
subunits that can belong to different subfamilies (Nayeem, 1994). To date, 19 different subunits 
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have been isolated: α1-6, β1-3, γ1-3, δ, ε, π, ρ1-3 and θ (for review see Michels, 2007). This 
multiplicity of subunits provides a huge number of potential subunit combinations, although 
certain subunits combined preferentially with each other. Native receptors contain at least diverse 
α and β subunits variants in combination with γ and δ subunits. The expression of the different 
GABAAR subtypes is spatially and developmentally regulated (for review see McKernan, 1996). 
Ionotropic GABAARs are primarily permeable to chloride (Cl-) ions, but other anions, 
such as bicarbonate (HCO3-) can also be carried by the channel pore, although with lower 
efficiency. When GABA binds extracellularly to the GABAAR, it induces a conformational 
change in the channel protein which increases the permeability of the ion pore to Cl- and HCO3-. 
Once GABA is removed from the synaptic cleft, the channel comes to a closed state and can, 
after desensitization, be re-opened. 
GABAARs can also be activated by structural analogues of GABA, such as muscimol, a 
natural product from the hallucinogenic mushroom Amanita muscaria, and synthetic analogs 
including 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridine-3-ol (THIP), piperidin-4-sulfuric acid (P4S) 
and isoguvacine (see Macdonald, 1994). 
During the early 1980´s, a chloride-independent GABA response was described in the rat 
brain. This was mediated by a metabotropic receptor that was termed GABAB receptor (Hill, 
1981 in Owens, 2002). GABAB receptors are located both pre- and postsynaptically and have 
different mechanisms at these locations to regulate cell excitability: presynaptic inhibition occurs 
through reduction in transmitter release; postsynaptic inhibition occurs by activation of potassium 
currents that hyperpolarize the neurons (Bormann, 1988 in Owens, 2002).  
 
2.2 Neuromodulation 
Neuromodulation could be described as any small change in chemical and electrical 
properties of nerve cells (Kaczmarek and Levitan, 1987). It’s a fundamental process regulating 
synaptic transmission and plasticity, neuronal networks and behavior. The molecules that are 
involved in neuromodulatory phenomena are called neuromodulators. An example of a very 
important neuromodulator of the CNS is adenosine (Ribeiro et al., 2003). 
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2.2.1 Adenosine 
Adenosine is a naturally occurring purine nucleoside which has been believed to play 
modulatory roles in a variety of tissue and physiological circunstances (Dunwiddie and Masino, 
2001). The first suggestion that adenosine and its precursor adenosine triphosphate (ATP) might 
affect neuronal function was advanced 80 years ago by Drury and Szent-Györgyi (1929). 
However, only more than 40 years later, with the works about adenosine and ATP modulation on 
neuromuscular junction (Ginsborg and Hirst, 1972; Ribeiro and Walker, 1973) and cortical 
neurons (Phillis et al., 1974), adenosine started to be regarded as a neuromodulator. ATP, but not 
adenosine, can also behave as a neurotransmitter but most of its extracellular actions in the 
nervous system are due to its hydrolysis into adenosine by a cascade of ectoenzymes. 
Besides being produced from released ATP, adenosine is also released by most cells and 
modulates the activity of the nervous system by acting presynaptically (inhibiting or facilitating 
neurotransmitter release), postsynaptically and/or non-synaptically. Its actions are exerted by 
activation of high-affinity receptors (A1 and A2A), with larger physiological importance, by 
activation of low affinity receptors (A2B), with more relevance in pathophysiological conditions, 
and through A3 receptors, which are high affinity receptors in humans, but have a low density in 
most tissues (see Ribeiro et al., 2003). Adenosine receptors are G-protein coupled receptors with 
seven transmembrane domains and are linked to a variety of transduction mechanisms. In the 
CNS and periphery, activation of A1 receptors leads to an inhibition of synaptic transmission and 
neuronal excitability, while activation of A2A and A2B receptors leads to an increase in 
neurotransmitter release and excitation (Sebastião and Ribeiro, 1996). The properties of A3 
receptors in the brain are still not well understood (see Jacobson, 1998). 
The A1 receptors signal through inhibitory Gi and Go pathways and inhibit adenylyl 
cyclase (van Calker et al., 1979), activate inwardly rectifying K+ channels (Trussell and Jackson, 
1985), inhibit Ca2+ channels (Macdonald et al., 1986) and activate phospholipase C 
(PLC)/Protein kinase C (PKC) pathway (Kendall and Hill, 1988). They have a widespread 
distribution in the brain and are highly expressed in the hippocampus, brain cortex, cerebellum 
and some thalamic nuclei (Goodman and Snyder, 1982; see Ribeiro et al., 2003). Activation of 
adenosine A1 receptors induces neuroprotective actions in ischemic models as well as 
neuromodulatory effects on synaptic transmission by decreasing neurotransmitter release (e.g. 
Barrie and Nicholls, 1993; see Cunha, 2001) and reducing long-term changes in synaptic 
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efficiency (de Mendonça and Ribeiro, 1997). In addition to these synaptic effects, A1 receptors 
are believed to provide beneficial extra-synaptic effects, which are based on a decrease in brain 
metabolism (Haberg et al., 2000) and the control of astrocyte function (see van Calker and Biber, 
2005). 
In contrast to A1 receptors, A2A receptors are coupled to stimulatory Gs proteins - 
increasing adenylate cyclase activity and raising intracellular levels of cAMP - or Golf proteins 
(Corvol et al., 2001). They have a much more restricted distribution in the brain (see Ribeiro et 
al., 2003), being characteristic of dopamine enriched areas (e.g. Svenningsson et al., 1997). In the 
hippocampus, A2A receptors have been shown to increase synaptic transmission and excitability 
(Sebastião and Ribeiro, 1992; Cunha et al., 1994a), synaptic plasticity (de Mendonça and 
Ribeiro, 1994) and the evoked release of acetylcholine (Cunha et al., 1994b), glutamate (Lopes et 
al., 1999) and GABA (Cunha and Ribeiro, 2000). 
Less is known about the contribution of the low-affinity A2B and the low-density A3 
receptors. Given the low-affinity of A2B receptors for adenosine, it is suggested that they have an 
important role in pathological conditions when extracellular adenosine concentration rises (see 
Fredholm, 1997). The A3 receptors are found mostly in peripheral tissues and have been 
extensively studied in cells from the immune system (e.g. Rankumar et al., 1993). 
 
3. Techniques 
3.1 Electrophysiological recordings in hippocampal slices 
3.1.1 Tissue Preparation 
The explosion of research on central nervous system physiology and pharmacology starts 
with the reports of Yamamoto and McIlwain (1966a, b) and Richards and McIlwain (1967) who 
showed that brain tissue could be kept alive and healthy outside the body since synaptic activity 
and excitability of ex vivo mammalian brain slices remain similar to that observed in vivo. 
The brain slice preparation offers several technical advantages for the investigation of 
central nervous system, since the experimenter can directly and accurately control the 
environment of the slice; drugs can be applied in known concentrations either to the entire slice 
or to selected regions; the drugs could also be removed from the tissue when desired; recordings 
and stimulating electrodes can be placed accurately under visual control. 
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The slice preparation has been particularly predominant in hippocampal research. The 
hippocampal formation is a bilateral limbic structure, which in rat brain has a semicircular form. 
It is easily found and removed intact from the brain. In most cases, isolated hippocampi are cut 
into transverse slices (perpendicular to the septal-temporal axis). In this transverse hippocampal 
section, the laminar organization of neurons is visually recognizable and the intrinsic 
hippocampal circuitry is preserved, although significant longitudinal pathways also exist. 
The internal structure of the hippocampus has two interlocking C-shaped cell layers, one 
reversed in relation to the other, each with its own principal cell layer (see Figure 1). One “C” 
makes up “Cornu Ammonis” (CA), also known as the “Hippocampus proper”; the other “C” is 
made up of the Dentate Gyrus (DG) (see Lopes da Silva et al, 1990). 
According to Ramón y Cajal (1911), hippocampus Cornu Ammonis subdivides into CA1, 
CA2 and CA3 areas; it consists of seven layers: stratum moleculare; stratum lacunosum; stratum 
radiatum; stratum pyramidale (the principal cell layer); stratum oriens; alveus and epithelium. In 
the dentate gyrus three layers are considered: stratum moleculare; stratum granulosum (principal 
cell layer) and stratum polymorphum (Figure 1C). 
The hippocampus, when cut in slices, exhibits the main glutamatergic, excitatory, 
unidirectional circuit which involves three connected pathways known as the “trisynaptic” loop. 
First, the fibers coming from entorhinal cortex (EC) project to the granule cells of the dentate 
gyrus, via the perforant path. Second, the granule cells of the dentate gyrus project to the large 
pyramidal cells of CA3, via the Mossy Fibers (MF) system. Third and finally, the CA3 pyramidal 
cells project to the pyramidal cells of the CA1 area, via the Schaffer Collateral (SC) system 
(Lorent de No, 1934). The CA1 pyramidal cells also send their axons to the Subiculum (Sb) 
neurons, which in turn send the main hippocampal output back to the EC, forming the loop 
(Figure 1B). Associated with all the principal excitatory neurons outlined earlier are the 
inhibitory gamma-amino-butyric acid-containing (GABAergic) interneurons. 
The preparation of hippocampal slices starts by anesthesia of the animal (in this work a 
rat) and rapid extraction of the brain. The isolated brain is put into an ice-cold (4ºC) dissection 
buffer and the two hippocampi are dissected. The small temperature of the cutting solution 
decreases the cell metabolism and helps maintain the consistency of the cerebral tissue. The 
buffer is saturated with 95% O2 and 5% CO2 by bubbling this gas through the solution, to keep 
the pH at 7.40 (Schwartzkroin, 1981). 
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The two hippocampi are then cut transversally along the primary axis in slices of 300µm 
thickness and incubated in artificial Cerebrospinal Fluid (aCSF) or Krebs solution, equilibrated 
with 95% O2 and 5% CO2 at 35⁰C for 30 minutes, to ensure the energetic and functional recovery 
of the tissue (Fredholm et al., 1984). After this period, the slices are maintained at room 
temperature (RT) (22-24⁰C) for at least 1 hour before use in Patch-Clamp recordings. 
 
 
Figure 1. Diagram illustrating the hippocampal anatomy. 
(A) Localization of hippocampus in the rat brain. The cortical surface was partially removed for better visualization 
of hippocampal formation. 
(B) Schematic representation of a tranversal hippocampal slice with indication of the different areas and the main 
excitatory circuit.. 
(C) Representation of a section of CA1 and Dentate Gyrus (DG) area with the indication of the different layers. 
Adapted from Anderson et al., 1971 and Amaral and Witter, 1989. Obtained from Lopes, 2003. 
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3.1.2 Patch-Clamp 
Neher and Sakmann (1976) were the first to monitor the opening and closing of single ion 
channels in the membranes of cells by conductance measurements. In its early form, the 
resolution of this technique was limited by the relatively low (≈50MΩ) resistances that isolated 
the interior of the pipette from the bath, leading to a high background noise due to current leaks. 
Despite these early limitations, a new technique was born – the Patch-Clamp. Few years later, 
Neher and co-workers (see Neher, 1981) developed the gigaohm seal. They found that very high 
resistance (tens or even hundreds of GΩ) seals can form between the cell membrane and the tip 
of a clean pipette when gentle suction is applied to the pipette interior. The high resistance of the 
seal ensures that almost all of the current from the membrane patch flows into the pipette. Along 
with the gigaohm seal technique it was possible to gently pull the membrane patch with the 
attached pipette off the cell and study its trapped ion channels. Subsequently, it was found that 
the patch of membrane under the pipette tip could be removed, and once this had happened the 
electrode achieves direct electrical contact with the cell interior. As a result, the voltage across 
the entire cell membrane could be clamped, instead of the voltage across the tiny patch. This is 
how the technique came to be known as the whole-cell voltage-clamp. 
The voltage-clamp is often used to study one type of channels among the many present in 
a given cell. When this is the case, some procedures must be done to separate the currents 
through the channel of interest from the currents through any other channels. This can be 
achieved by selectively choosing the ionic composition of the pipette and/or the bath solution; by 
controlling the holding potential of the cell membrane; or by using different pharmacological 
agents that selectively block or activate specific channels or channel groups (see Sontheimer and 
Olsen, 2007 for review). 
Patch-clamp recordings can be performed in many different configurations that can 
involve the entire cell (whole-cell) or cell membrane excision and that may preserve (outside-out) 
or not (inside-out) the original exposure of the cell membrane to the extracellular medium. 
Recordings that maintain the cell structure can be performed in the cell-attached, whole-cell or in 
its variant, the perforated patch mode. Whereas the cell-attached mode allows only for activity of 
the channels inside the pipette limit to be studied, the whole-cell and perforated patch modes 
allow the measurements of the currents flowing through the entire population of channels in a cell 
membrane (see Lien et al., 1995 for review). The perforated patch is used mainly when there is 
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the need to maintain the intracellular machinery while retaining the access to both sides of the 
membrane. It uses specific perforating antibiotics that allow electrical continuity between cell 
cytoplasm and electrode, while blocking the dialysis of the cellular compartment (Horn and 
Marty, 1988; Korn and Horn, 1989). Antibiotics such as nystatin or amphotericin B form ion 
channels in cell membrane that are permeable to monovalent ions (Horn and Marty, 1988) but not 
to divalent ions such as Mg2+ or Ca2+ or to large molecules. It allows the study of intracellular 
signaling - and its impact on cellular electricity - from virtually intact cells. During classical 
whole-cell patch-clamp recordings, the patch under the pipette is ruptured and diffusion of 
cytoplasmic constituents out of the cell volume into the pipette occurs. This configuration is the 
most widely used mode as it is easy to obtain and offers the possibility of applying modulators or 
drugs to the intracellular solutions in order to study signaling cascades associated to known 
phenomena. 
 
3.2 Immunohistochemistry 
Throughout the development of research science, precise quantitative and cellular 
localization techniques have become increasingly desirable. Techniques based on immunology, 
as immunofluorescence, have been available for about 40 years (Jantzie et al, 2007). 
The introduction and use of immunochemistry to neuroscience as a tool to study the 
localization and identification of proteins has revolutionized basic science techniques. 
Immunohistochemistry has established itself as one of the most powerful and widely used 
methods to identify cell types, transmitter-specific neurons, neuropeptides and receptors (Cuello 
et al., 1983 in Jantzie et al., 2007). It was conceptualized on the principle that the immune system 
produces antibodies against foreign antigenic substances. The antigen-antibody (Ag-Ab) reaction 
in immunohistochemistry usually takes place between two proteins: the antigen, which is 
localized and immobilized in a fixed section of tissue, and may also be a polysaccharide, nucleic 
acid or other polymer; and the antibody, which is a glycoprotein and is diluted in buffer, covering 
the tissue section and is free during the incubation period (Montero, 2003). The final result of the 
immunohistochemistry is dependent on optimizing the reactions and interactions between these 
macromolecules and amplifying the signal so that it will be visible to the experimenter, by using 
microscopy techniques. 
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4. Methods 
4.1 Animals 
All experiments were performed with young-adult Wistar rats (3-5 weeks old, Harlan-
Italy), handled according to the Portuguese law on Animal Care and European Union guidelines 
(86/609/EEC). 
The animals were housed in the local Animal House on a 12hours light/dark cycle and 
were provided food and water ad libitum. Care was taken so as to reduce the number of used 
animals to the absolutely necessary. 
 
4.2 Preparation of hippocampal slices for electrophysiological recordings 
The animals were anesthetized with Isoflurane (in 1,2-Propylenglycol 50% (v/v)) in an 
anesthesia chamber. The first indications of anesthesia include the lack of a righting reflex and 
reduction in respiratory rate. A noxious stimulus (i.e. toe pinch) was also applied to ensure deep 
plane of anesthesia. If no response was noted, the animal was sacrificed by decapitation in a 
guillotine. The brain was quickly removed, hemisected and the hippocampus used to obtain 
transverse slices (300µm) cut on a Vibratome (VT1000 S; Leica, Germany) in ice-cold dissecting 
solution containing (in mM): sucrose 110; KCl 2.5; CaCl2 0.5; MgCl2 7; NaHCO3 25 NaH2PO4 
1.25; glucose 7, oxygenated with 95% O2 and 5% CO2, pH 7.4. 
Slices were first incubated for 30 minutes at 35⁰C in aCSF, containing (in mM): NaCl 
124; KCl 3; NaH2PO4 1.25; NaHCO3 26; MgSO4 1; CaCl2 2 and glucose 10, pH 7.4, gassed with 
95% O2 and 5% CO2, and used after recovering for at least 1hour at RT. 
Individual slices were fixed with a grid in a recording chamber (5-6mL) and continuously 
superfused by a gravitational superfusion system at 2-3mL/min with aCSF at RT. Unless 
otherwise stated, drugs were added to this superfusion solution and reached the recording 
chamber within 2-3min. 
Whole-cell recordings were obtained from pyramidal cells located at CA1 stratum 
pyramidale. CA1 pyramidal cells were visually identified using a Carl Zeiss Axioskop 2FS 
upright microscope (Jena, Germany) equipped with infrared video microscopy and differential 
interference contrast optics. To further ensure the recorded cells were indeed CA1 pyramidal 
cells, firing patterns were routinely determined at the beginning of each experiment. Pyramidal 
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cells were recognizable for their slow firing frequencies (≤5Hz), longer action potentials 
(≥0,8ms) and for featuring spike-frequency adaptation (Figure 2).  
 
 
Figure 2. Firing pattern of a CA1 pyramidal cell. 
Representative train of action potentials evoked in current-clamp mode by current injection (for 500ms) sufficient to 
depolarize the cell 0mV, 10mV and 20mV from its resting membrane potential. Pyramidal cells show a firing pattern 
characterized by slow firing frequencies (≤5Hz), longer action potentials (≥0,8ms) and spike-frequency adaptation. 
Calibration: 200ms; 20mV. 
Patch pipettes were made from borosilicate glass capillaries (1.5mm outer diameter, 0.86 
inner diameter, Harvard Apparatus) in two stages on a pipette puller (PC-10 Puller, Narishige 
Group). The resistances of the recording pipettes was 4-9MΩ when filled with an internal 
solution containing (in mM): K-gluconate 125; KCl 11; CaCl2 0.1; MgCl2 2; EGTA 1; HEPES 
10; MgATP 2 ; NaGTP 0.3 and phosphocreatine 10, pH 7.3, adjusted with KOH (1M), 280-
290mOsm. 
Whole-cell GABA-evoked postsynaptic currents (PSCs) were recorded in a voltage-clamp 
mode (Vh = -80mV) with an EPC-7 amplifier (List Biologic, Campbell, CA). Offset potentials 
were nulled directly before giga-seal formation. Immediately after establishing whole-cell access, 
the membrane potential of the neurons was measured in current-clamp mode and was 66 ± 6,6 
mV (mean ± SD; n=94; liquid junction potential corrected). Small voltage steps (5mV, 10ms) 
were given before PSCs recordings to monitor input (membrane and series) resistance. The 
holding current was also constantly monitored throughout the experiment and when any of these 
parameters varied by more than 20%, the experiment was rejected. Voltage errors caused by 
small changes in input resistance were not corrected. The current signal was filtered using a 3 and 
10 kHz three-pole Bessel filter of an EPC-7 (List Medical) amplifier.  
GABAAR-mediated currents were evoked using a pressure ejection system (PicoPump 
PV820; World Precision Instruments). A micropipette containing muscimol (30µM) was 
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positioned near the cell bodies and pulses of pressure were applied (single 10ms puffs, 6psi, 
applied at 2min intervals). The experimental protocol was initiated at least 30min after the whole-
cell formation. 
Data acquisition was under the control of WinLTP 0.96 (Anderson, 1991-2009) software 
program (Anderson and Collingridge, 2007). 
 
4.3 Pharmacological tools 
CGS 21680 (2-[4-(2-p-carboxyethyl)phenylamino]-5’N-ethylcarbozamidoadenosine) 
(selective agonist of A2A receptor), muscimol (selective agonist of GABAAR) and 2-
Methylbutane were obtained from Sigma-Aldrich (MO, USA). CPA (N6-cyclopentyladenosine) 
(selective agonist of A1 receptor), DPCPX (1,3-dipropyl-8-cyclopentylxanthine) (selective 
antagonist of A1 receptor), TTX (tetrodotoxin citrate) (Sodium-channel blocker), DL-AP5 (DL-
2-Amino-5-phosphonopentanoic acid) (selective NMDA receptor antagonist), CNQX (6-cyano-
7-nitroquinoxaline-2,3-dione) (competitive AMPA/kainate receptor antagonist) were from Tocris 
Bioscience (Bristol, UK). Gabazine (SR-95531) (selective and competitive GABAAR antagonist) 
was obtained from Ascent Scientific (Bristol, UK). Isoflurane was from Abbot Laboraties 
(Barcelona, Spain) and 1,2-Propylenglycol from Merck (NJ, USA). CGS 21680 (5mM), CPA 
(5mM) and CNQX (100mM) were prepared as a stock solution in dimethylsulfoxide (DMSO). 
Muscimol (10mM) and DL-AP5 (50mM) were prepared as a stock solution in NaOH (1M). TTX 
(1mM) and Gabazine (5mM) were made up in water and DPCPX (5mM) was made up in 99% 
DMSO/1% NaOH (1M) (v/v). The percentage of DMSO in each experiment did not exceed 
0.01%. Stock solutions were aliquoted and stored at -20°C until use. Dilutions of these stock 
solutions to the final concentration were made freshly before each experiment. 
 
4.4 Gelatin embedding, tissue sectioning and immunohistochemistry 
The different immunohistochemistry protocols that have been used to optimize the 
technique are described in annex (see Optimizations in annex) 
For gelatin embedding protocol, the animals were anesthetized and decapitated as 
described in section 4.2. The hippocampal formation was removed from the brain and fixed in 
4% paraformaldehyde (PFA) overnight at 4ºC. After rinsing in ice-cold PBS (phosphate-buffered 
saline, NaCl 137mM; KCl 2,7mM; KH2PO4 1,5mM; Na2HPO4 8mM), the hippocampi were 
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transferred to 30% sucrose in PBS at 4ºC until the tissue sinks. It was incubated for 30/45 
minutes in 15% sucrose/7,5% gelatin in  PBS at 37ºC and then transferred to the same solution, at 
RT to form the gelatin blocks. 2-Methylbutane was cooled in liquid nitrogen (-70ºC to -80ºC) and 
the gelatin blocks with the hippocampi were dipped for 30 to 60 seconds to completely freeze the 
tissue. The blocks were kept at -80ºC until use for cryosectioning. 
Sections with 12µm thick were made in a cryostat (CM3050 S; Leica, Germany), 
collected in Superfrost slides (Thermo Scientific, Germany) and stored at -20ºC in cryoboxes 
with silica gel until use for immunohistochemistry. 
The immunohistochemistry protocol starts with an initial step of desgelatinization in PBS 
at 37ºC to remove the gelatin and an additional wash with Glycine (0,1M in PBS), for 10 minutes 
at RT, to remove any trace of PFA from the tissue. The permeabilization was made in 0,1% 
Triton (in PBS) for 15minutes at RT and the blocking with fetal bovine serum (FBS) in 
PBSTween (0,1% Tween-20 in PBS) for 1 hour also at RT. The slices were then incubated with 
the primary antibody (primary antibodies used in this work are described in Table 1) over night at 
4ºC. The primary antibody was rinsed off with PBSTween and the secondary antibody (see Table 
2) was applied to the sections for 90 minutes at RT. From now on the plates were protected from 
light since we were working with fluorophores. All antibodies were prepared in PBSTween. The 
secondary was also rinsed off with PBSTween and slices were incubated with 4',6-diamidino-2-
phenylindole (DAPI, a fluorescent stain that binds strongly to the DNA) for 5 minutes at RT. The 
slices were mounted in mowiol, let dry overnight at RT and stored in a cryobox, with silica gel at 
-20ºC. Visualization was done with an inverted widefield fluorescence microscope (Zeiss 
Axiovert 200M, Germany). 
Antibody Species Supplier Dilution
Adenosine A1 Receptor Rabbit polyclonal antibody Affinity BioReagents  (CN: PA1-041A) 1/500
Adenosine A2A Receptor, clone 7F6-G5-A2 Mouse monoclonal antibody Upstate Biotechnology (CN: 05-717) 1/500
GABAA Receptor α2, N-19 Goat polyclonal antibody Santa Cruz Biotechnology (CN: sc-7350) 1/50
GABAA Receptor β2/3, clone 62-3G1 Mouse monoclonal antibody Upstate Biotechnology (CN: 05-474) 1/500
MAP2*, clone AP20 Mouse monoclonal antibody Chemicon (CN: P11137) 1/500
GFAP**, clone GA5 Mouse monoclonal antibody Chemicon (CN:P14136) 1/100
Table 1. Primary antibodies used in this work 
*Microtubule-associated protein 2 
**Glial fibrillary acidic protein 
CN – Catalogue Number 
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Antibody Fluorophore Supplier Dilution
Goat anti-mouse AlexaFluor 568 Invitrogen 1/500
Goat anti-rabbit AlexaFluor 488 Invitrogen 1/500
Rabbit anti-goat AlexaFluor 568 Invitrogen 1/500
 
 
Table 2. Secondary antibodies used in this work  
4.5 Data analysis 
Values refer to mean peak amplitude of GABA-evoked macroscopic currents and are 
represented as mean ± Standard Error of the Mean (SEM) from n experiments. 
Statistical significance was assessed by a two-tailed Student’s t test for the experimental 
versus control condition and one-way ANOVA followed by Bonferroni’s Multiple Comparison 
test was used when comparing between three or more groups. A p value of 0.05 or less was 
considered to account for significant differences. Statistical analyses were conducted with the 
Prism Version 5.00 for Windows (GraphPad Software). 
Immunohistochemistry images were edited with AxioVision 4 (Version 4.7.2; Carl Zeiss 
Imaging Solutions) and ImageJ (version 1.42q; NIH, USA) for widefield microscopy images and 
LSM Image Browser (Version 4.2.0; Carl Zeiss Imaging Solutions) for confocal microscopy 
images. 
 
5. Results 
The activity of GABAARs was assessed through whole-cell patch-clamp experiments by 
applying a selective GABAAR agonist, muscimol (30µM) onto the soma of pyramidal cells 
located in stratum pyramidal of CA1 hippocampal area. 
Muscimol was used instead of GABA to guarantee that metabotropic GABAB receptors 
were not activated and to ensure that these evoked currents were GABAAR-mediated only. 
Indeed, the muscimol-evoked postsynaptic currents were completely blocked with 1µM of 
Gabazine, a selective GABAAR antagonist (Figure 3). 
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Figure 3. Patch-clamp recordings of GABAAR-mediated postsynaptic currents (PSCs). 
(A, B) Recordings were performed in pyramidal cells located in stratum pyramidale (SP) of CA1 area of rat 
hippocampal slices. 
(C) Higher amplification of the hippocampal slice showing the soma of a pyramidal cells in whole-cell patch-clamp 
configuration.  
(D) Representative traces of PSCs induced by pressure application of muscimol (30µM). In the right panel in D the 
Gabazine (1µM) was added to the bathing solution fully preventing the PSCs. 
CA1 – Cornu Ammonis 1; CA3 – Cornu Ammonis 3; DG – Dentate Gyrus; SO – stratum oriens; SP – stratum 
pyramidale; SR – stratum radiatum; 
Calibration: A – 300µm; B – 120µm; C – 10µm D – 400ms, 200pA. 
5.1 Adenosine A2A receptor modulation of GABAAR currents 
Adenosine acts in the hippocampus as a modulator of neuronal excitability either by 
directly modulating the glutamatergic excitatory circuit or by modification of GABA inhibition 
(see Ribeiro et al., 2003). Previous studies have focused on this modulatory role of adenosine 
both in glutamatergic communication (Sebastião and Ribeiro, 1996) and in presynaptic GABA 
function (Cunha and Ribeiro, 2000). However, much less is known about any possible 
modulatory role of adenosine on responses of the postsynaptic cell to GABA.  
It has been previously shown that increased levels of cAMP and activation of Protein 
Kinase A (PKA) changes GABAAR currents in both dentate gyrus (Kapur and MacDonald, 1996) 
and pyramidal cells (Poisbeau et al., 1999). Since adenosine A2A receptors are frequently coupled 
to cAMP signalling and to an increase in PKA activity (Corvol et al., 2001) it was hypothesized 
that adenosine A2A receptors could have a modulatory effect on GABAAR-mediated PSCs. 
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After achieving a stable baseline (at least 10min) of muscimol-evoked PSCs amplitudes, 
an adenosine A2A receptor agonist, CGS 21680 (30nM) was applied to the bath solution for 50 
min. CGS 21680 was used in a concentration selective for A2A receptors (Jarvis et al., 1989) and 
known to activate A2A receptors in hippocampal slices (Sebastião and Ribeiro, 1992). However, it 
did not change the peak amplitude of muscimol-evoked currents (PSCs amplitude during the last 
10min of CGS 21680 application, comparing with the baseline: 101% ± 2,1% of baseline, (n=6, 
p=0,715) (Figure 4). 
 
 
Figure 4. Activation of adenosine A2A receptors did not change GABAAR-mediated postsynaptic currents (PSCs). 
(A) Time course plot of results obtained in 6 experiments showing that CGS 21680 (30nM), a selective agonist of 
A2A receptors (applied during the time indicated by the horizontal bar) does not affect muscimol (a selective 
GABAAR agonist)-evoked currents recorded from CA1 pyramidal cells (Vh=-80mV). GABAAR-mediated PSCs 
were evoked every 2 minutes. The PSCs were normalized to the 10 minutes before CGS 21680 application (100% = -
-106pA ± 9,7pA) and are plotted against time. No statistically significant differences were found between current 
amplitudes before and 50min after CGS 21680 application (n=6, p=0,715 under the two-tailed Student’s t test). Error 
bars represent SEM. 
(B) Illustrative current recordings. Arrows represent brief (10ms) application of muscimol (30µM) to the soma of the 
pyramidal cell. (1) PSC evoked 10 minutes before CGS 21680 superfusion. (2) PSC evoked during the last 10 
minutes of CGS 21680 application. Calibration: 400ms, 50pA. 
It would have been of great interest to look for cellular co-localization between A2A and 
GABAARs in hippocampal slices, in order to understand the absence of effect of A2A receptors on 
GABAAR currents. However, problems with the immunohistochemistry protocol did not allow us 
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to fulfill this goal in time (see annex for details and section 6 for further discussion). 
Nevertheless, these electrophysiological results suggest that GABAAR-mediated PSCs are not 
changed by activation of adenosine A2A receptors. 
 
5.2 Adenosine A1 receptor modulation of GABAAR currents 
Adenosine A1 receptors are much more abundant in the hippocampus than A2A receptors 
(see Ribeiro et al., 2003) and are also associated with adenylyl cyclase signalling (van Calker et 
al., 1979), but, in this case, by decreasing its activity and reducing cAMP levels. It has also been 
observed that A1 receptors are highly expressed in the postsynaptic density (Rebola et al., 2003), 
providing a molecular evidence for a role of A1 receptor in the control of dentritic integration. We 
therefore hypothesized that A1 receptors, unlike A2A receptors, could modulate postsynaptic 
GABAAR-mediated currents. 
To test this hypothesis we applied to the bath solution an adenosine A1 receptor agonist, 
CPA (10nM) (Moos et al., 1985), after achieving a stable baseline amplitude of muscimol-
evoked currents. We observed that the superfusion of CPA (10nM) triggered a rapid inhibition of 
GABAAR-mediated currents that reached a plateau within <45min. The peak amplitudes of 
muscimol-evoked responses, measured 50 min after initiating the superfusion of CPA, were 
reduced in 12 of 17 cells tested (70,6%) to 54% ± 3,9% (n =12, p<0.0001; Figure 5). This effect 
of CPA (10nM) was not reversed within 30 ± 14 min after washing it out from the bath in 5 
experiments tested (54% ± 4,0%, n=5, p=0,955 compared with CPA (10nM); Figure 5A).   
To test for the reversibility of the CPA (10nM) effect, we applied to the bath solution a 
selective adenosine A1 receptor antagonist, DPCPX (50nM) (Bruns et al., 1987), after 50min of 
CPA superfusion. If the CPA effect on GABAAR-mediated currents is reversible, and the 
apparent irreversibility shown in Figure 3 results only from the impossibility of obtaining a 
complete tissue clearance of CPA during the washout period, it was expected that the antagonist, 
DPCPX, would compete with the agonist for A1 receptor binding, and facilitate the recovery of 
the inhibitory effect of CPA. Indeed, 15min of DPCPX application induced the recovery of the 
muscimol-evoked currents towards 84% ± 6,5% of the baseline (n=3, p<0,001 compared with 
CPA (10nM); Figure 6). Thus, these experiments suggest that DPCPX (50nM) is able to partially 
recover the inhibitory effect induced by 10nM of CPA on GABAAR-mediated currents. Taken 
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together, the above mentioned data suggest that adenosine A1 receptor activation inhibits 
GABAAR-mediated postsynaptic currents.  
 
Figure 5. Activation of adenosine A1 receptors inhibits GABAAR-mediated postsynaptic currents (PSCs). 
(A) Time course plot of results obtained in 12 experiments showing the effect of CPA (10nM), a selective adenosine 
A1 receptor agonist (applied as indicated by the horizontal bar) on muscimol-evoked currents. Normalized PSCs 
amplitudes are plotted against time (100% = -260pA ± 37pA). CPA significantly reduced (p<0,0001, two-tailed 
Student’s t test as compared with 10 minutes before drug application) the peak amplitude of GABAAR-mediated 
currents (n=12). After washout, the muscimol-evoked currents did not recover to the baseline level (n=5, p=0,955 
compared with CPA (10nM), two-tailed Student’s t test). Error bars represent SEM. 
(B) Illustrative currents. Arrows represent brief (10ms) application of muscimol (30µM) to the soma of the pyramidal 
cell. (1) PSC evoked 10 minutes before CPA application. (2) PSC evoked during the last 10 minutes of CPA 
application. Calibration: 400ms, 200pA. 
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Figure 6. DPCPX facilitates recovery of GABAAR-mediated currents after inhibition by CPA. 
(A) Time course plots of results obtained in a representative experiment showing the facilitatory action of DPCPX 
(50nM) on the recovery of muscimol-evoked currents after 50 minutes of CPA superfusion. Normalized peak 
amplitude of GABAAR-mediated postsynaptic currents is plotted against time (100% = -154pA ± 1,7pA). 
(B) Histogram showing the mean effect of CPA superfusion on peak amplitude of GABAAR-mediated currents (n=3, 
**p<0,001 compared with 100%, two-tailed Student’s t test) and the recovery (n=3, *p<0,05 compared with CPA, 
two-tailed Student’s t test). 100% = -260 ± 106pA. Error bars represent SEM. 
To confirm that the inhibitory effect of CPA on muscimol-evoked currents is an A1 
receptor mediated effect of this agonist, we tested the effect of CPA (30nM) in the presence of an 
adenosine A1 receptor antagonist DPCPX (100nM). The concentration of CPA was increased to 
30nM (where CPA is still selective for A1 receptors (Moos et al., 1985)) to obtain a more robust 
effect. Indeed, at this concentration CPA inhibited PSCs to 60% ± 2,6% (n=5; p<0,0001) in 5 out 
of 6 cells (83,3%). As expected, DPCPX (100nM) prevented the inhibitory effect of CPA (30nM) 
on GABAAR-mediated PSCs (100% ± 0,6% of the baseline, n=5, p=0,503 compared with 
absence of CPA; p<0,001 compared with CPA alone; Figure 7). From data shown in Figure 7 we 
can also observe a small increase in GABAAR-mediated PSCs after 30min of DPCPX (100nM) 
superfusion (113% ± 1,0% of the baseline, n=5, p<0,001 compared with control), suggesting a 
tonic inhibition by endogenous extracellular adenosine on GABAAR-mediated currents through 
A1 receptors. After CPA (30nM) application, and still in the presence of DPCPX (100nM), there 
was a small decrease of GABAAR-mediated PSCs towards the control baseline level (113% ± 
1,0% to 100% ± 0,6%, n=5, p<0,001; Figure 7). This was expected since CPA and DPCPX are 
competitive ligands, competing for the same binding site of adenosine A1 receptor.  
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Figure 7. DPCPX prevents the effect of CPA on GABAAR-mediated postsynaptic currents (PSCs). 
(A) Time course plots of results obtained in 5 experiments showing that DPCPX (100nM) prevents the effect of CPA 
(30nM) on muscimol-evoked currents. DPCPX also unmasked the inhibition of PSCs by endogenous extracellular 
adenosine. Normalized PSCs amplitudes are plotted against time (100% = -172pA ±21pA). Horizontal bars represent 
the drugs application periods. 
(B) Summary of data. DPCPX (100nM) induced a statistically significant increase in GABAA-mediated PSCs (n=5, 
***p<0,001, two-tailed Student’s t test). The CPA (30nM) effect on GABAAR-mediated PSCs was prevented by 
DPCPX (100nM) (n=5, ###p<0,001, one-way ANOVA followed by Bonferroni’s Multiple Comparison test), and CPA 
occluded the desinhibition by DPCPX (n=5, ###p<0,001, one-way ANOVA followed by Bonferroni’s Multiple 
Comparison test). Data shown in the first 3 bars on the left were obtained in the same cells (100% = -172pA ± 21pA) 
using the protocol illustrated in A; the data shown in the fourth bar was obtained in cells that had never been in the 
presence of DPCPX (100% = -314pA ± 36pA). Error bars represent SEM. 
I next isolated the GABAergic component from any interference of both fast and slow 
glutamatergic transmission by blocking it with CNQX (10µM), a selective antagonist of 
AMPA/Kainate receptors, and DL-AP5 (50µM), a selective NMDA receptor antagonist. Action 
potentials were also blocked with tetrodotoxin (TTX, 500nM), a Na+ channel blocker. As 
expected, the effect of CPA (30nM) was maintained in these conditions, decreasing the 
muscimol-evoked currents to 60% ± 8,3% (n=4, p<0,05 compared with the baseline; Figure 8) 
indicating that the adenosine A1 receptor modulation on GABAAR-mediated PSCs is not 
dependent of excitatory inputs on CA1 pyramidal cells. 
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Figure 8. Excitatory inputs on CA1 pyramidal cells have no effect on adenosine A1 receptor modulation of 
GABAAR-mediated postsynaptic currents (PSCs). 
(A) Time course of data obtained in a representative experiment showing the effect of CPA (30nM) on muscimol-
evoked currents when both fast and slow glutamatergic transmission was blocked by 10µM of CNQX (a selective 
antagonist of AMPA/Kainate receptors) and 50µM of DL-AP5 (a selective NMDA receptor antagonist) and when 
action potentials were blocked by 500nM of tetrodotoxin (TTX, a Na+ channel blocker). 100% = -320pA ± 4,7pA. 
(B) Summary of data. The mean effect of CPA (30nM) on GABAAR-mediated PSCs (n=4; *p<0,05, two-tailed 
Student’s t test; 100% = -232pA ± 48pA) recorded in the presence of 500nM of TTX (a Na+ channel blocker), 10µM 
of CNQX (a selective antagonist of AMPA/Kainate receptors) and 50µM of DL-AP5 (a selective antagonist of 
NMDA receptor) was not statistically different from the one observed with 30nM CPA alone (n=4, p=0,819, two-
tailed Student’s t test; 100% = -314pA ± 36pA). The effect of CPA in the presence and in the absence of the blockers 
was tested in different experiments. Error bars represent SEM. 
6. Discussion 
The regulation of GABA-mediated inhibitory synaptic transmission is of great importance 
to control neuronal activity and excitability. Most of what it is known about adenosine 
modulation of inhibitory transmission has focused on the control of presynaptic GABA function. 
Here I describe a postsynaptic effect of adenosine, through A1, but not A2A receptors, on 
GABAAR-mediated currents.  
 
6.1 Adenosine A2A receptor activation does not change GABA R-mediated 
PSCs 
A
 In our experimental conditions, an adenosine A2A receptor agonist (CGS 21680) induced 
no changes in GABAAR-mediated PSCs in pyramidal cells of CA1 area of the hippocampus. 
There are evidences that show that cAMP/PKA and PKC transduction pathways (both usually 
coupled to adenosine receptors signalling) are involved in GABAAR phosphorylation (McDonald 
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et al., 1998; Krishek et al., 1994) and consequently modifying the receptor function (Kapur and 
Macdonald, 1996; Poisbeau et al., 1999). Given this, it would be very interesting to look for co-
localization between A2A receptors and GABAARs in hippocampal CA1 pyramidal cells (see 
annex and section 6.3) in order to understand the absence of interaction between the two 
receptors. It could happen that A2A receptors and GABAARs do not co-localize in these particular 
cells and consequently GABAARs are not affected by A2A receptor signalling. Other hypothesis is 
that GABAARs at synapses of CA1 pyramidal cells preferentially contain subunits 
phosphorylated by different kinases (other than PKA or PKC). Nevertheless, I consider this last 
possibility unlikely because a PKA effect on GABAAR was already described in CA1 pyramidal 
cells (Poisbeau et al., 1999) and adenosine A1 receptors were capable of changing the GABAAR 
currents (Figure 5), probably through one of these transduction pathways (see discussion below). 
It was also described that A2A receptors are more abundantly located in the presynaptic active 
zone of nerve cells (Rebola et al., 2005) comparing to its density on postsynaptic and 
extrasynaptic zone. This could also explain the inexistence of an A2A receptor effect on 
postsynaptic GABAARs currents. However, it should be pointed out that A2A receptors are also 
present postsynaptically (Lee et al., 2003; Rebola et al., 2005) and could exert a modulatory 
function there (Li and Henry, 1998; Dias, Sebastião et al., submitted to press). It may happen that 
the density of A2A receptors is not enough to trigger a modulatory response on GABAergic 
currents. 
 
6.2 Activation of adenosine A1 receptors inhibits GABAAR-mediated PSCs 
 In contrast to A2A receptor agonist, the adenosine A1 receptor agonist, CPA, significantly 
attenuated GABAAR currents in the vast majority of hippocampal CA1 pyramidal cells tested. 
While performing single-cell electrophysiology recordings, it is usual that not all the cells tested 
respond to a given pharmacological treatment. This is interpreted as cell to cell variability among 
the entire cell population. The number of non-responding cells was less than one-half of the 
number of tested cells when using the lower CPA concentration and might be attributable to 
differences in density/distribution of adenosine receptors, to differences in efficiency of 
downstream signalling pathways, or, less likely, to difficult penetration of the drug in some 
slices. 
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The effect of adenosine A1 receptor activation on GABAAR currents was hardly reversed 
after washing out CPA from the bathing solution. This phenomenon could result from the 
impossibility of totally removing CPA out from the hippocampal tissue, preserving the effect 
long after the start of the washout period. Another explanation for this would be an irreversible 
effect downstream the A1 receptor activation. That is, once the A1 receptor is activated, it could 
trigger a signalling pathway that would induce a persistent decrease in GABAAR currents that 
becomes independent of A1 receptor activation. This last possibility does not fit the data in the 
experiments shown in Figure 6, clearly showing that the adenosine A1 receptor antagonist, 
DPCPX, was able to compete with CPA and to recover the amplitude of GABAAR currents 
nearly towards to the pre-control level. Another way to confirm the reversibility of A1 receptor 
activation effect would be to allow more time for a complete clearance of CPA from the tissue, 
by extending the washout period. However, this would greatly increase the timecourse of the 
protocol for a patch-clamp experiment, probably leading to cell fading and disruption of the seal 
long before the complete washout. 
Another finding in the present study was the ability of endogenous adenosine, through 
activation of A1 receptors to tonically inhibit GABAAR currents in the hippocampus. This 
phenomenon was revealed by the disinhibitory effect of an adenosine A1 receptor antagonist, 
DPCPX, on GABAAR PSCs. Further studies are required to elucidate this issue, namely by 
performing protocols where extracellular adenosine is removed from the tissue with adenosine 
deaminase (ADA); ADA, in amounts up to 2u/mL selectively (Cunha et al., 1996) and efficiently 
(Lee et al., 1981) removes endogenous extracellular adenosine in the hippocampus.  
The adenosine A1 receptor mediated effect on GABAAR-currents was independent of both 
excitatory inputs arriving to pyramidal cells and glutamatergic transmission mediated by 
AMPA/Kainate or NMDA receptors. This could be concluded from the experiments with TTX, 
to prevent the firing of action potentials, and with selective antagonists of AMPA/Kainate and 
NMDA receptors. No change was observed in A1 receptor modulation on GABAAR-currents in 
these conditions, showing that we are really in the presence of a postsynaptic effect upon 
GABAergic currents, free from any excitatory contamination. 
My results clearly show a postsynaptic effect of A1 receptors on GABAAR-mediated 
currents, contrast with previous studies recording afferent evoked GABAergic currents and 
reporting that A1 receptors in the hippocampus do not affect GABAergic transmission either pre- 
23 
 
Diogo Rombo  Adenosine modulation of GABAA receptor currents 
 
or postsynaptically (Yoon and Rothman, 1991; Lambert and Teyler, 1991). Other studies, where 
miniature spontaneous inhibitory postsynaptic currents were recorded, reported that A1 receptors 
modulate GABAergic transmission at the presynaptic, but not postsynaptic level (Jeong et al., 
2003; Yum et al., 2008). This discrepancies might be easily explained by the preparation and the 
protocol used. The present study was performed with acutely prepared hippocampal slices of 3 to 
5 weeks old rats while others used immature hippocampal neurons (Joeng et al., 2003), where the 
distribution of A1 receptors is still diffuse in the cell soma of pyramidal cells (Ochiishi et al., 
1999). Also, the previous studies recorded spontaneous GABAergic miniature synaptic currents 
(Jeong et al., 2003; Yum et al., 2008), restricting the evaluation of adenosine A1 receptor effect to 
the synaptic active zone, while in our experimental conditions the stimulation was applied to the 
cell soma, activating both postsynaptic and extrasynaptic  GABAARs. Therefore, it is likely that 
most of the presently observed A1 receptor mediated action is exerted at extrasynaptic GABAA 
receptors. The extrasynaptic GABAA receptors are manly involved in a persistent form of 
GABAergic inhibition consisting of a continuous receptor activity known as “tonic” inhibition. 
Small but tonic GABAergic currents have been already observed in both pyramidal cells (Bai et 
al., 2001) and inhibitory interneurons (Semyanov et al., 2003) in the CA1 area of the 
hippocampus. This may play an important role in synaptic signal integration, as well as in disease 
conditions such as certain types of seizures where ambient concentration of GABA is decreased 
(see Galanopoulou, 2008). The modulation of tonic inhibitory receptors would represent a 
promising strategy for the development of new anticonvulsant drugs. 
Further studies are needed to investigate the signalling cascade downstream the A1 
receptor activation that leads to the decrease in GABAAR-currents. The A1 receptors are known 
to be coupled to pertussis toxin sensitive G-proteins (Gi and Go) and mainly signal through 
cAMP/PKA or PLC/PKC transduction pathways (see Dunwiddie and Masino, 2001). As 
mentioned above, GABAARs could be phosphorilated by PKA or PKC, depending on their 
subunit composition (McDonald et al., 1998; Krishek et al., 1994). This makes these two kinases 
very good candidates for mediating the A1 receptor effect on GABAAR currents. One way to 
investigate this transduction pathway would be by intracellularly applying pharmacological tools 
that interfere with the mentioned signalling cascades, while registering the GABAAR currents and 
activating A1 receptors. 
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In summary, with the present work I clearly show that A1 receptors inhibit GABAAR-
mediated PSCs in rat hippocampal CA1 pyramidal cells. 
Future studies aimed at elucidating how adenosine modulates the inhibitory GABAergic 
inputs that arrive to inhibitory interneurons will be necessary. This would give us a more 
complete picture of how hippocampal inhibition is controlled by adenosine. 
 
6.3 Immunohistochemistry experiments 
As already mentioned (see section 4.4), we had some problems obtaining good 
immunostainings of rat hippocampal slices. In this study we tried three different protocols to 
characterize the cellular distribution of A1, A2A and GABAA receptors in the hippocampus. We 
used an immunohistochemistry instead of immunocitochemistry technique because: (1) 
immunohistochemistry preserves the citoarchitecture of the hippocampus; (2) our 
electrophysiological results are from CA1 pyramidal cells and it would be interesting to 
distinguish the distribution of the three receptors in the different hippocampal areas. The A1 and 
A2A receptor antibodies used in this work were already successfully used by others in 
immunocitochemistry experiments (Kimura, 2003; Rebola et al., 2005). The GABAA receptor 
antibodies (see Table 1) were chosen considering the distribution of GABAAR subunits in the 
hippocampus, where α2 and β3 subunits are the predominant ones (Sperk et al., 1997). The 
procedure that involved gelatin embedding and cryostat sectioning of the hippocampus proved to 
be the best approach to preserve the tissue and obtain intact slices for immunohistochemistry. 
The next step would be trying the A1, A2A and GABAA receptor staining in these conditions. The 
time-consuming optimization procedure (see annex) prevented to conclude the 
immunohistochemistry experiments during the time-frame (1year) of this master project. 
 
7. Conclusion 
The present results provide direct functional evidence of the ability of A1 receptors to 
inhibit postsynaptic GABAAR currents in hippocampal CA1 pyramidals cells. This phenomenon 
is completely independent of excitatory glutamatergic synaptic transmission and is tonically 
exerted by endogenous extracellular levels of adenosine in the hippocampus. 
The A2A receptors, unlike A1 receptors, do not appear to modulate GABAA currents in the 
same hippocampal neurons. 
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Further studies about the adenosine modulation of inhibitory signals on inhibitory 
interneurons are required to fully understand how adenosine controls inhibition in the 
hippocampus.  
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Annexes 
Optimizations 
This section is dedicated to describe the immunohistochemistry protocols that have been 
applied during this master work and that allowed us to optimize the techniques to our 
experimental needs. Brief descriptions of the methods used during the optimization process, as 
well as data obtained during optimizations will be shown and discussed. 
 
Immunohistochemistry 
Immunohistochemistry of hippocampal slices cut on the Vibratome 
Our laboratory has some previous experience on immunocitochemistry of hippocampal 
cell cultures. However it was the first time that we tried to apply immunotechniques to 
hippocampal slices. We started with a protocol identical to those previously used for 
immunocitochemistry with small changes. Briefly, after decapitation under deep isofluorane 
anesthesia, the hippocampi were dissected and fixed. The fixation period varied from 2.5 hours to 
overnight with 4% PFA. Shorter fixation periods lead to better retention of antigenicity, but affect 
structural preservation and hamper the cut of the slices (Cuello et al, 1983 in Jantzie et al, 2007). 
Since the hippocampi were cut on a Vibratome (VT1000 S; Leica, Germany) and we wanted thin 
slices, the overnight fixation proved to be the best choice, allowing us to cut slices with 40µm 
thickness. 
Other parameters that needed to be optimized for hippocampal slice immunostaining were 
the permeabilization and the blocking times. The permeabilization was done with PBSTg (1% 
Triton and 0,1% gelatin in PBS) for 1 hour to 2.5 hours. Overfixation (overnight with 4% PFA) 
could be compensated by increasing the permeabilization period and, consequently, the antibody 
penetration. However, it can also degrade the brain tissue and compromise the overall structure of 
the section. Blocking reaction is important to reduce nonspecific binding of antibodies and to 
limit background staining. Here we used 0,25% gelatin in PBS (PBSg) and tried 1 hour and 1.5 
hours. Again, there is a compromise between reducing nonspecific staining and loosing the 
specific binding of the primary antibodies. 
Although the aim of the immunohistochemistry work was to identify any possible co-
localization of adenosine receptors and GABAARs in CA1 area of hippocampal slices, we used 
single staining during all the optimization steps. The primary antibodies used were adenosine A2A 
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receptor antibody and GABAAR α2 antibody (see Table 1). A dendrite marker MAP2 
(microtubule-associated protein 2) antibody was used as positive control. The antibody dilutions 
were also optimized for each protocol (see Table 1 for optimized dilutions) and were incubated 
over night at 4ºC. The secondary antibodies (Table 2) were used according to Table A1. The 
incubation was for 2 hours at RT.  
ii 
 
Figure A1. Immunohistochemistry of hippocampal slices with 40µm thick seen in an inverted widefield fluorescence 
microscope.  
(A) Negative control showing the background staining associated with the non specific binding of an AlexaFluor568 
(red) labeled goat anti-mouse antibody (1/500 dilution). 
(B) Negative control treated with a rabbit anti-goat antibody associated with AlexaFluor568 (red) (1/500 dilution). 
(C) The mouse anti-Adenosine A  receptor antibody (1/500 dilution) staining revealed by a goat anti-mouse coupled 
to non specific binding. 
(D) Immunohistochemistry to reveal GABA
2A
to AlexaFluor568 (red) shows no difference compared with the negative control (A), being most of the staining 
probably due 
A receptor was carried out using a goat anti GABAA receptor α2 antibody 
 staining. However, the antibody proved to be non specific 
(1/50 dilution) and a rabbit anti-goat conjugated with AlexaFluor568 (red) (1/500 dilution) and shows small red dots 
(indicated by black arrows) that could represent specific
for GABAA receptor (Valente et al., unpublished). 
(E) Positive control showing the MAP2 antibody staining (1/500 dilution) revealed by a goat anti-mouse antibody 
conjugated to AlexaFluor568 (red; 1/500 dilution). 
All calibration bars represent 200µm. 
Table A1. List of primary antibodies used in this work and the secondary antibodies associated.  
 
Primary antibody Secundary antibody Color
Adenosine A1 Receptor Goat anti-rabbit AlexaFluor488 Green
Adenosine A2A Receptor, clone 7F6-G5-A2
GABAA Receptor β2/3, clone 62-3G1
MAP2*, clone AP20
GFAP**, clone GA5
GABAA Receptor α2, N-19 Rabbit anti-goat AlexaFluor568
Goat anti-mouse AlexaFluor568
Red
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An illustrative picture seen in an inverted widefield fluorescence microscope (Zeiss 
Axiovert 200M, Germany) is shown in Figure A1, where we can see the positive control MAP2 
staining (Figure A1E) but no A2A receptor staining (Figure A1C) compared with the negative 
control (Figure A1A). This could be explained by the huge background noise that is masking the 
specific staining for A2A receptor. The GABAAR α2 staining shows small dots (black arrows, 
Figure A1D) that are not seen in negative control (Figure A1B) and could represent specific 
staining for this receptor. However, complementary data from our lab revealed the unspecificity 
of the antibody (Valente et al., unpublished), making us change it to a GABAAR β2/3 antibody 
from Upstate Biotechnology (see Table 1). 
Since this protocol was not working with the A2A receptor antibody, we decided to change 
the pro
 xylene and embedding in paraffin blocks using an 
automa
Container Fluid Time (hours)
1 Alcohol 70% 1,5
2 Alcohol 95% 1,5
cedure to paraffin inclusion, more often used with tissue slice immunostaining. 
 
Paraffin inclusion 
Paraffin wax is one of the most used embedding mediums for histology. It is easily 
handled and allows the preparation of very thin sections of the tissue. 
Before starting the immunostaining protocol, the tissue has to go through a paraffin 
embedding step, a desparafinization step and antigen recovery. Briefly, the dissected hippocampi 
(as described in section 4.2) were fixed in 4% PFA overnight and were processed through 
dehydration in graded ethanol, clearing in
tic processing and embedding equipment (Leica TP1020, Germany; Leica EG1150H, 
Germany) (Table A2). 
Table A2. Paraffin processing schedule.  
 
 
7 Xilol 1
8 Xilol 2
9 Paraffin 1
10 Paraffin 2
3 Alcohol 95% 1,5
4 Alcohol 100% 1
5 Alcohol 100% 1,5
6 Alcohol 100% 1,5
iii 
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Table A3. Desparaffine processing schedule.  
 
 
For antigen retrieval there are th
8 Water 3
9 Destilated water Until antigen recover
The paraffin blocks were cut at 5µm in a microtome (Leica RM2145, Germany) and 
collected in Superfrost slides (Thermo Scientific, Germany). The desparaffinization consists in 
rehydrate the samples as shown in Table A3. 
ree buffers that are mainly used: boric acid, 
ethylenediaminetetracetic acid (EDTA) and citrate buffer. The last one was already tested in the 
lab by other master student and it destroyed the hippocampal tissue, so we only tried the other 
two. We heated the slides in a microwave oven in boric acid or EDTA during 15 or 30 minutes. 
The slides were then transferred to PBS until use in immunostaining. 
The permeabilization of the slides for antigen penetration was done with PBSTg (1% 
Triton and 0,1% gelatin in PBS) for 10 minutes and the blocking with 0,25% gelatin in PBS for 
30 min tes. The visualization rescence microscope (Zeiss 
Axiove
en in an inverted widefield 
fluores
Only the MAP2 staining was revealed by this protocol (Figure A2F, 
G). Th
rs are much 
less abundant in the hippocampus than MAP2.  
Container Fluid Time (minutes)
1 Xilol 10
2 Xilol 10
3 Alcohol 100% 2
4 Alcohol 100% 2
5 Alcohol 95% 2
6 Alcohol 95% 2
7 Alcohol 70% 2
u  was made in an inverted widefield fluo
rt 200M, Germany). 
The antibodies used were the MAP2 antibody as positive control, the A2A receptor 
antibody, and also the A1 receptor antibody and the GABAAR antibody specific for β2/3 subunits 
(see Table 1). The secondary antibodies (Table 2) were used according to Table A1.  
In Figure A2 are represented immunohistochemistry images se
cence microscope (Zeiss Axiovert 200M, Germany). There was no difference between 
negative controls (Figure A2A and A2C) and A1 receptor, A2A receptor and GABAAR β2/3 
staining neither with 15 minutes (Figure A2B; A2D and A2E) nor 30 minutes (data not shown) of 
boric acid antigen retrieval. 
ese results could be explained by the sequential process of fixation, dehydration and 
paraffin-embedding that probably resulted in a loss of immunoreactivity of antigen epitopes. This 
was more evident in the slides marked for A1, A2A and GABAARs, since the recepto
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Neg. Ctr.
AlexaFluor488
A
A1
B
Neg. Ctr.
AlexaFluor568
C
A2A
D
GABAAE F
CA1
DG
MAP2
G
MAP2
Figure A2. Immunohistochemistry of paraffin embedded hippocampal slices with 5µm thick seen in an inverted 
widefield fluorescence microscope. 
(A) Negative control showing the unspecific binding of AlexaFluor488 (green) labeled goat anti-rabbit antibody 
(1/500 dilution), treated with acid boric for 15 minutes. 
(B) The slides treated with A1 receptor antibody revealed by a goat anti-rabbit antibody conjugated with 
AlexaFluor488 (green; 1/500 dilution) show no differences compared with the negative control (A). 
(C) Negative control showing the goat anti-mouse antibody coupled to AlexaFluor568 (red; 1/500 dilution) staining.  
(D) Staining of A2A receptor antibody (1/500 dilution) showed by a goat anti-rabbit antibody conjugated with 
AlexaFluor568 (red; 1/500 dilution), treated for 15 minutes with boric acid. We can see no difference when 
compared with the negative control (C). 
(E) The GABAA receptor β2/3 antibody (1/50 dilution) revealed by AlexaFluor568 (red) labeled goat anti-mouse 
antibody (1/500 dilution) shows no specific signal when compared with the negative (C) or positive control (G). 
(F, G) Positive control showing the specific staining of MAP2 antibody (1/500 dilution) revealed by a goat anti-
mouse antibody conjugated to AlexaFluor568 (red; 1/500 dilution). 
Images A-E and G represent the CA1 area of the hippocampus (Calibration bars represent 50µm); F shows an
With ethylenediaminetetracetic acid (EDTA) treatment we were not able to see any 
l MAP2) in neither 15 minutes nor 30 minutes of 
tion of the 
section
 
 
overview of the hippocampus with CA1 and Dentate Gyrus (DG), (Calibration bars represent 200µm). 
antibody staining (even for the positive contro
incubation periods (data not shown). 
The slides were also visualized in a laser scanning confocal microscope (Zeiss LSM510 
META, Germany) and the results were the same (data not shown). 
 
Gelatin embedding and cryostat sectioning 
We also tried another protocol that involved a gelatin embedding procedure followed by 
cryostat sectioning of the hippocampus. Cryosectioning usually leads to fragmenta
 during cutting and low adherence between the section and the slide after mounting. 
However, these limitations can be overcome with a suitable embedding medium as gelatin. 
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Figure A3. Immunohistochemistry of gelatin embedded and cryostat sectioned hippocampus (12µm) seen in a laser 
scanning confocal microscope. 
(A-C) Hippocampal glial cells marked with DAPI (B) and GFAP antibody (1/100 dilution) revealed by a goat anti-
mouse conjugated with AlexaFluor568 (red; 1/500 dilution) (A) and merged image (C). 
(D-F) Immunohistochemistry identification of DAPI (E) and MAP2 (1/500 dilution; marker for neuronal dendrites) 
e goat anti-mouse antibody conjugated with AlexaFluor568 (red; 1/500 dilution) 
staining. 
Gelatin
The method is described in section 4.4 and has been successfully applied by Domingos 
Henriq  embryos (Fior and Henrique, 2005; Rocha 
et al., 2
 with adenosine receptors antibodies 
and GA
 does not require the use of organic solvents as clearing agents as in paraffin embedding 
and it needs less time for the complete embedding protocol. 
ue’s lab (IMM, Lisbon, Portugal) with chicken
009); we tested it in hippocampal tissue and used a MAP2 antibody and a glial fibrillary 
acidic protein (GFAP) antibody (a marker for glia) as controls. 
We had staining of both MAP2 (1/500 dilution; Figure A3A,C) and GFAP (1/100 
dilution; Figure A3D,F) antibodies (see Table 1), revealed with AlexaFluor568 labeled goat anti-
mouse antibody (red; 1/500 dilution; see Table 2), when compared with the negative control 
(Figure A3G-I). This is a good indicator for future staining
BAAR β2/3 subunit antibody (see section 7 for discussion).  
 
DAPIAlexaFluor568 Merged
CA1 CA1 CA1
G H I
DAPIMAP2 Merged
CA1 CA1
A B C
CA1
DAPIGFAP Merged
CA1 CA1
D E F
CA1
revealed by a goat anti-mouse coupled to AlexaFluor568 (red; 1/500 dilution) (D) and the merged image (F). 
(G-I) Negative control showing th
Calibration bars represent 50µm. 
